Abstract
Great effort has been invested in the treatment of chronic bacterial prostatitis, but with rather disappointing results. The best cure rates reported using trimethoprim-sulfamethoxazole and various quinolones for 4 weeks-30 months vary from 32% to 71% (Meares 1975; Andriole 1991; McGuire and Lytton 1976; Weidner et al. 1991; Paulson and DeVere White 1978). The disappointing results are probably due to poor drug penetration into the prostate (Stamey et al. 1970; Aagaard and Madsen 1991; Meares 1992). To study the principles contributing to drug penetration into the various prostatic compartments, several animal models (dogs and rats) have been used. The results should, however, be interpreted with caution before being applied clinically. Some drug penetration studies have been carried out in patients undergoing transurethral prostatic surgery, but these studies involved mainly the hypertrophied prostate, not the normal and rarely the chronically infected prostate.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Aagaard J, Madsen PO (1991) Bacterial prostatitis: new methods of treatment. Urology 37: 4–8
Aagaard J, Knes J, Madsen PO (1991) Prostatic tissue levels of ofloxacin. Urology 38: 380
Andriole VT (1991) Use of quinolones in treatment of prostatitis and lower urinary tract infection. Eur J Clin Microbiol Infect Dis 10 (4): 342–350
Baumueller A, Madsen PO (1977) Experimental bacterial prostatitis in dogs. Urol Res 5: 211
Dørflinger T, Larsen EH, Gasser TC, Madsen PO (1986) The concentration of various quinolone derivatives in the dog prostate. In: Weidner W (ed) Therapy of prostatitis. Experimental and clinical data. Zuckschwerdt, Munich, pp 35–39
Eickenberg HU, Scharfenberger L, Waterman NG (1976) A new model for measuring concentration of antibiotics in prostatic interstitial fluid. Infection 4 (2): 108
Fair WR, Cordonnier J J (1978) The pH of prostatic fluid: a reappraisal and therapeutic implication. J Urol 120: 695
Frimodt-Møller N, Maigaard S, Madsen PO, Naber KG (1979) Co-trimazine distribution in the canine prostate. Infection 7 (4): 349
Gasser TC, Larsen EH, Dorflinger T, Madsen PO (1986) The influence of various body fluids and pH on E. coli MIC of quinolone derivatives. In: Weidner W (ed) Therapy of prostatitis. Experimental and clinical data. Zuckschwerdt, Munich, pp 50–53
Huggins C, Masina MH, Eichelberger L, Wharton JD (1939) Quantative studies of the prostatic secretion. I. Characteristics of the normal secretion, the influence of thyroid, suprarenal and testes extirpation and androgen substitution on the prostatic outlet. J Exp Med 70: 543
Larsen EH, Gasser TC, Dorflinger T, Madsen PO (1986) The concentration of various quinolone derivatives in the human prostate. In: Weidner W (ed) Therapy of prostatitis. Experimental and clinical data. Zuckschwerdt, Munich, pp 40–44
Madsen PO, Kjaer TB, Baumueller A, Mellin H-E (1976) Antimicrobial agents in prostatic fluid and tissue. Infection 4 (2): 154
Madsen PO, Kjaer TB, Baumueller A (1976b) Prostatic tissue and fluid concentration of trimethoprim and sulfamethoxazole. Urology 8 (2): 129
Madsen PO, Whalen PR (1978) Interaction between antimicrobial agents and prostatic tissue extract and fluid. Infection 6 (1): 75
Mason MM, Keefe F, Boria T (1961) Specialized surgery of canine bladder and prostate gland. Isolation and collection of prostatic fluid. J Am Vet Assoc 135: 1007
McGuire EJ, Lytton B (1976) Bacterial prostatitis: treatment with trimethoprim-sulfamethoxazole. Urology 7: 499
Meares EM (1975) Longterm therapy of chronic bacterial prostatitis with trimethoprim-sulfamethoxazole. Can Med Assoc J Suppl 112: 22
Meares EM (1992) Prostatitis and related disorders. In: Walsh PC, Retik AB, Stamey TA et al. (eds) Campbell’s urology, 6th edn. Saunders, Philadelphia, pp 807–822
Nielsen KT, Madsen PO (1988) Temafloxacin (A63004), difloxacin (A56619) and ciprofloxacin treatment of acute prostatitis. An experimental model in rats (Abstr). 2nd International Symposium on New Quinolones, Aug 25–27, Geneva
Paulson DF, DeVere White R (1978) Trimethoprim-sulfamethoxazole and minocycline-hydrochloride in the treatment of culture-proved bacterial prostatitis. J Urol 120: 184
Reeves DS, Ghilchik M (1970) Secretion of the antibacterial substance trimethoprim in the prostatic fluid of dogs. Br J Urol 42: 66
Robb CA, Carrol PT, Tippett LO, Landston JB (1971) The difference of selected sulfonamides, trimethoprim and diaveridine into prostatic fluid of dogs. Invest Urol 8: 679
Stamey TA (1972) Urinary infection in males. In: Urinary infections. Williams and Wilkins, Baltimore, p 161
Stamey TA, Meares EM, Winningham G (1970) Chronic bacterial prostatitis and the diffusion of drugs into the prostatic fluid. J Urol 103: 187
Weidner W, Schiefer HG, Brähler E (1991) Refractory chronic bacterial prostatitis: a re-evaluation of ciprofloxacin treatment after a median follow-up of 30 months. J Urol 146 (2): 350–352
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1994 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Madsen, P.O., Drescher, P., Gasser, T.C. (1994). Basis for Antibacterial Treatment of Prostatitis: Experimental and Clinical Pharmacokinetic Studies and Models. In: Weidner, W., Madsen, P.O., Schiefer, H.G. (eds) Prostatitis. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-78181-0_9
Download citation
DOI: https://doi.org/10.1007/978-3-642-78181-0_9
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-78183-4
Online ISBN: 978-3-642-78181-0
eBook Packages: Springer Book Archive